AIMS/HYPOTHESIS: Type 2 diabetes mellitus with hyperinsulinaemia is a state of sympathetic nerve hyperactivity, which can develop subsequently in non-diabetic first-degree offspring of patients with type 2 diabetes. Although both type 2 diabetes and sympathetic activation are major cardiovascular risk factors, the level of sympathetic nerve activity is as yet unknown in offspring of type 2 diabetic patients who are ostensibly normal. We therefore sought to quantify sympathetic nerve activity and its relationship to plasma insulin levels in ostensibly normal offspring of patients with type 2 diabetes, relative to a matched normal control group with no family history of type 2 diabetes. SUBJECTS AND METHODS: In two closely matched groups comprising 23 non-diabetic offspring of type 2 diabetic patients and 23 normal control individuals we measured resting muscle sympathetic nerve activity (MSNA) as the mean frequency of multi-unit bursts of MSNA and single units of MSNA (s-MSNA) with defined vasoconstrictor properties. RESULTS: In offspring of type 2 diabetic patients, the fasting plasma levels of insulin (7.4+/-0.80 microU/ml) and s-MSNA (45+/-3.2 impulses/100 beats) were greater (p<0.009 and p<0.003) than those in control persons (4.6+/-0.76 microU/ml and 32+/-3.1 impulses/100 beats, respectively). MSNA bursts and derived insulin resistance followed similar trends. Sympathetic nerve activity was significantly correlated to insulin levels (p<0.0002) and resistance (p<0.0001) in offspring of type 2 diabetic patients, but not in control subjects. CONCLUSIONS/ INTERPRETATION: Sympathetic activation occurred in normal non-diabetic offspring of patients with type 2 diabetes in proportion to their plasma insulin levels. Our data indicate the presence of a mechanistic link between hyperinsulinaemia and sympathetic activation, both of which could play a role in the subsequent development of cardiovascular risk factors.
AIMS/HYPOTHESIS: Type 2 diabetes mellitus with hyperinsulinaemia is a state of sympathetic nerve hyperactivity, which can develop subsequently in non-diabetic first-degree offspring of patients with type 2 diabetes. Although both type 2 diabetes and sympathetic activation are major cardiovascular risk factors, the level of sympathetic nerve activity is as yet unknown in offspring of type 2 diabeticpatients who are ostensibly normal. We therefore sought to quantify sympathetic nerve activity and its relationship to plasma insulin levels in ostensibly normal offspring of patients with type 2 diabetes, relative to a matched normal control group with no family history of type 2 diabetes. SUBJECTS AND METHODS: In two closely matched groups comprising 23 non-diabetic offspring of type 2 diabeticpatients and 23 normal control individuals we measured resting muscle sympathetic nerve activity (MSNA) as the mean frequency of multi-unit bursts of MSNA and single units of MSNA (s-MSNA) with defined vasoconstrictor properties. RESULTS: In offspring of type 2 diabeticpatients, the fasting plasma levels of insulin (7.4+/-0.80 microU/ml) and s-MSNA (45+/-3.2 impulses/100 beats) were greater (p<0.009 and p<0.003) than those in control persons (4.6+/-0.76 microU/ml and 32+/-3.1 impulses/100 beats, respectively). MSNA bursts and derived insulin resistance followed similar trends. Sympathetic nerve activity was significantly correlated to insulin levels (p<0.0002) and resistance (p<0.0001) in offspring of type 2 diabeticpatients, but not in control subjects. CONCLUSIONS/ INTERPRETATION: Sympathetic activation occurred in normal non-diabetic offspring of patients with type 2 diabetes in proportion to their plasma insulin levels. Our data indicate the presence of a mechanistic link between hyperinsulinaemia and sympathetic activation, both of which could play a role in the subsequent development of cardiovascular risk factors.
Authors: Robert J Huggett; Eleanor M Scott; Stephen G Gilbey; John B Stoker; Alan F Mackintosh; David A S G Mary Journal: Circulation Date: 2003-12-15 Impact factor: 29.690
Authors: Timothy B Curry; Casey N Hines; Jill N Barnes; Madhuri Somaraju; Rita Basu; John M Miles; Michael J Joyner; Nisha Charkoudian Journal: Clin Auton Res Date: 2014-03-01 Impact factor: 4.435
Authors: Fernando Silva Carneiro; Fernanda R C Giachini; Victor V Lima; Zidonia N Carneiro; Romulo Leite; Edward W Inscho; Rita C Tostes; R Clinton Webb Journal: J Sex Med Date: 2008-01-21 Impact factor: 3.802
Authors: E F S Castro; C T Mostarda; B Rodrigues; I C Moraes-Silva; D J Feriani; K De Angelis; M C Irigoyen Journal: Braz J Med Biol Res Date: 2015-02-13 Impact factor: 2.590
Authors: Maria K Svensson; Stina Lindmark; Urban Wiklund; Peter Rask; Marcus Karlsson; Jan Myrin; Joel Kullberg; Lars Johansson; Jan W Eriksson Journal: Cardiovasc Diabetol Date: 2016-06-28 Impact factor: 9.951
Authors: Nicole M Novielli; Baraa K Al-Khazraji; Philip J Medeiros; Daniel Goldman; Dwayne N Jackson Journal: PLoS One Date: 2012-10-05 Impact factor: 3.240